{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-109371","form_type":"8-K","ticker":"BCLI","cik":"0001137883","company_name":"BRAINSTORM CELL THERAPEUTICS INC.","filed_at":"2021-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.292877+00:00","generated_at":"2026-06-29T07:46:45.344867+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Brainstorm CFO Preetam Shah resigns, Controller Alla Patlis named Interim CFO","bullets":["CFO Preetam Shah resigned effective Aug 31, 2021; no disagreement with the Company or Board.","Controller Alla Patlis appointed Interim CFO effective upon Shah's departure if no permanent CFO named.","Patlis has served as Controller since Dec 2012 and previously as Interim CFO in 2015 and 2016-2017.","No change in Patlis's current compensation for the additional Interim CFO role.","Company plans to interview candidates for a permanent CFO successor."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-109371","json":"https://secwatch.observer/filing/0001104659-21-109371.json","markdown":"https://secwatch.observer/filing/0001104659-21-109371.md","text":"https://secwatch.observer/filing/0001104659-21-109371.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921109371/0001104659-21-109371-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921109371/tm2125922d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T07:46:45.344867+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"23849bf5d7","claim":"Preetam Shah resigned as Chief Financial Officer at BRAINSTORM CELL THERAPEUTICS INC..","evidence_excerpt":"On August 20, 2021, Preetam Shah, the Chief Financial Officer (and principal financial and accounting officer) of Brainstorm Cell Therapeutics Inc. (the “Company”), provided the Company with notice of his intent to resign from the Company, effective August 31, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921109371/0001104659-21-109371-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"fd86a3663a","claim":"Alla Patlis was appointed as Interim Chief Financial Officer at BRAINSTORM CELL THERAPEUTICS INC..","evidence_excerpt":"The Board of Directors of the Company has appointed Alla Patlis, the Company’s current Controller, as the Company’s Interim Chief Financial Officer, principal financial officer and principal accounting officer, effective upon Mr. Shah’s resignation if a permanent Chief Financial Officer is not appointed prior to that time.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921109371/0001104659-21-109371-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}